Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1–2 trial

BACKGROUND: Taxane–platinum combinations have shown promising activity in metastatic castration-resistant prostate cancers in single-group clinical studies but not in randomised trials. Distinct biological subsets of the disease might derive the greatest benefit from the addition of platinum. We aim...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Oncol
Main Authors: Corn, Paul G, Heath, Elisabeth I, Zurita, Amado, Ramesh, Naveen, Xiao, Lianchun, Sei, Emi, Li-Ning-Tapia, Elsa, Tu, Shi-Ming, Subudhi, Sumit K, Wang, Jennifer, Wang, Xuemei, Efstathiou, Eleni, Thompson, Timothy C, Troncoso, Patricia, Navin, Nicholas, Logothetis, Christopher J, Aparicio, Ana M
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6858999/
https://ncbi.nlm.nih.gov/pubmed/31515154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(19)30408-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados